Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06634810 · ClinicalTrials.gov registry record · NA

Comprehensive Patient-Centered Home-based Care Coaching for COPD Self-management

A NA study of Chronic Obstructive Pulmonary Disease, sponsored by Icahn School of Medicine at Mount Sinai.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
1
Study location

NCT06634810: Recruiting NA study of Chronic Obstructive Pulmonary Disease, sponsored by Icahn School of Medicine at Mount Sinai.

NCT06634810 is a NA study of Chronic Obstructive Pulmonary Disease that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 300 participants, below the 1,750-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06634810, a NA study of Chronic Obstructive Pulmonary Disease, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
1
Study location

Study Summary

The Icahn School of Medicine at Mount Sinai will conduct a randomized controlled trial of a self-management support intervention for predominantly minoritized and low-income adults with chronic obstructive pulmonary disease (COPD). The trial will focus on comprehensive screening and targeted management of barriers to COPD control, incorporating home-based pulmonary rehabilitation and oral steroid and antibiotic prescribing for pre-emptive treatment of COPD exacerbations. The research team will compare this intervention with an attention control group to evaluate the effects on medication adherence, COPD symptoms, inhaler technique, physical activity and exercise capacity at 6 months, and at 12 months to examine sustainability of treatment effects. The research team will also examine hospitalizations and emergency department visits at 12 months. The study will recruit 300 participants from the Mount Sinai Health System in Manhattan, Queens, and Brooklyn, ensuring diverse representation. Health coaches from the VNS Health will deliver the intervention, guided by a detailed training manual. Weekly conference calls will address logistical and protocol-related issues.

Primary Outcome

The COPD Assessment Test (CAT) is a validated measure of the impact of COPD on a person's life. COPD symptoms will be measured by self-report using the CAT. Full range from 0-40, with higher scores indicating a more severe impact of COPD on a patient's life.

Interventions

  • BEHAVIORAL Self-Management Support
  • BEHAVIORAL COPD Education

Study Locations (1)

New York

  • Ichan School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2024-09-25
Est. Completion 2027-01-31
Phase NA

What NCT06634810 shows while recruiting

NCT06634810 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,750-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (83% lower).

The record links to 1 condition, with Chronic Obstructive Pulmonary Disease appearing as the primary indexed condition, and to 2 interventions - of which Self-Management Support is the first listed.

NCT06634810 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT06634810 about?

NCT06634810 is a clinical study titled "Comprehensive Patient-Centered Home-based Care Coaching for COPD Self-management". The Icahn School of Medicine at Mount Sinai will conduct a randomized controlled trial of a self-management support intervention for predominantly minoritized and low-income adults with chronic obstructive pulmonary disease (COPD). The trial will focus on comprehensive screening and targeted managem...

What is the current status of trial NCT06634810?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2024-09-25. Estimated completion is 2027-01-31.

What conditions does trial NCT06634810 study?

This clinical trial studies the following conditions: Chronic Obstructive Pulmonary Disease.

What interventions are being tested in trial NCT06634810?

The interventions under investigation include: Self-Management Support (BEHAVIORAL), COPD Education (BEHAVIORAL).

Who is sponsoring clinical trial NCT06634810?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06634810 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Obstructive Pulmonary Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06634810's enrollment target sits among peer trials

300 34th of 86 higher than 53 of 86 other Chronic Obstructive Pulmonary Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Obstructive Pulmonary Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06634810, the US trial registry maintained by the National Library of Medicine. NCT06634810 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.